Home Immunity Covid infection, MIS-C may not boost children’s immunity to Omicron

Covid infection, MIS-C may not boost children’s immunity to Omicron


Children who previously had Covid-19 or the inflammatory disease MIS-C, associated with the virus, are not protected against the new variant of Omicron, a study has found.

The study, published in Nature Communications, showed that vaccination does provide protection, however.

Although Covid is rare and mild in children, some of those infected faced severe multisystem inflammatory syndrome (MIS). The United States Centers for Disease Control and Prevention (CDC) defines MIS-C as a condition in which different parts of the body can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes or the gastrointestinal organs.

“I hear parents say, ‘Oh, my child had Covid last year’. But we found that antibodies produced by previous infections in children do not neutralize Omicron, which means unvaccinated children remain sensitive to Omicron,” said Adrienne Randolph of Children’s Hospital Boston.

The researchers obtained blood samples from 62 children and adolescents hospitalized with severe Covid, 65 children and adolescents hospitalized with MIS-C and 50 outpatients who had recovered from mild Covid-19. All samples were taken in 2020 and early 2021, before the emergence of the Omicron variant.

In the lab, they exposed the samples to a pseudovirus (derived from SARS-CoV-2, but stripped of its virulence) and measured how well the antibodies in the samples were able to neutralize five different variants of SARS-CoV- 2 of concern: Alpha, Beta, Gamma, Delta and Omicron.

Overall, children and adolescents showed some loss of antibody cross-neutralization against all five variants, but the loss was more pronounced for Omicron.

“Omicron is very different from previous variants, with many mutations on the spike protein, and this work confirms that it is able to evade the antibody response,” Randolph said. “Unvaccinated children remain susceptible.”

In contrast, children who had received two doses of the Covid-19 vaccine had higher neutralizing antibody titers against all five variants, including Omicron.

Randolph hopes this data will encourage parents to get their children and teens vaccinated. A Food and Drug Administration panel will meet on June 15 to consider the authorization of Covid vaccines for children under 5.



(Only the title and image of this report may have been edited by Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear reader,

Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.

As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.

Support quality journalism and subscribe to Business Standard.

digital editor